Skip to main content


Independence Blue Cross promotes Obadiah Sang to VP of Corporate Development and Strategic Investments

Newly created role will provide strategic oversight for innovative growth, diversification

Independence Blue Cross (Independence) announced the promotion of Obadiah Sang to Vice President of Corporate Development and Strategic Investments.

Sang has more than 10 years of experience in corporate development, investing, and market strategy. In this new role, he will provide strategic oversight for mergers, acquisitions, divestitures, and strategic investing. Sang will oversee Independence’s strategic innovation portfolio and lead the company’s pursuit of new and innovative ways to grow business and drive diversification.

“Obadiah is well-respected among his peers and business partners as a strategic thinker who knows how to execute. We look forward to his leadership as we continue to grow and work to make meaningful and measurable differences in improving our members’ health,” said Mike Vennera, executive vice president and chief strategy, corporate development, and information officer at Independence Blue Cross.

Since joining Independence in 2020, Sang has played a key role on several strategic initiatives on behalf of the company, including:

  • Independence’s expanded relationship with Penn Medicine centered on Penn Medicine’s purchase of a minority equity stake in Tandigm Health. Penn’s long-term commitment to work with Tandigm focuses on primary care and aims to improve patient outcomes and contain costs.
  • Independence’s investment in Quartet Health to achieve speed to quality mental health care for all patients. The partnership builds on Independence’s whole-person health initiative.

Sang holds board observer roles across several of Independence’s strategic innovation portfolio companies.

Obadiah received a bachelors in finance from Metropolitan State University and his MBA from the University of Iowa, Tippie College of Business.